Company / AR per Share
Moderna AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.48
FY2025
5-year range
$0.48 / $7.96
FY2021-FY2025
Trend
-49.1%
vs FY2024
Sector context
#68 of 113
Health Care
What the data says
At $0.48, Moderna's ar per share ranks #68 of 113 in the Health Care sector. AR per Share has declined for 4 consecutive years, from $7.96 in FY2021 to $0.48 in FY2025.
Based on SEC 10-K filings.
0.48 in FY2025 with a 5-year CAGR of -35.1%.
Declined from $2.32 to $0.48 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -48.2%
- 5-Year CAGR
- -35.1%
- 10-Year CAGR
- -
Sector benchmark
#68 of 113 in Health CareTop 60% of 113This company $0.48 Sector average $28.83
▼
-98.3% below sector average
Key checks
Key Insights
- Moderna's ar per share has declined for 4 consecutive years.
- In FY2025, ar per share decreased 49.1% year-over-year.
- Ranks #68 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.48 | -49.1% |
| FY2024 | $0.94 | -59.6% |
| FY2023 | $2.32 | -32.6% |
| FY2022 | $3.44 | -56.8% |
| FY2021 | $7.96 | +92.5% |
| FY2020 | $4.13 | +25212.3% |
| FY2019 | $0.02 | -90.9% |
| FY2018 | $0.18 | -2.7% |
| FY2017 | $0.18 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026